Pharmexx Brazil begins consolidation

The Pharmexx Brazil, who plays with medical detailing to submission of new releases of the pharmaceutical industry, just start your process of internationalization, in the wake of the increase in the number of high-cost medicines registered in Brazil and in Latin America. The company designs close this year with a turnover of $40 million, increased R 25% from the observed last year. The goal, until 2020, is triple the revenue through acquisitions and early operations in Colombia and in Mexico.